Theratechnologies Inc.

Doing business as Exopep

UEI
PEK6G581HZK5
CAGE
L07W8
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
theratech.com
Founded
1993
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Theratechnologies Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Trogarzo (pharmaceutical) Contract · 36C24921N0223 Veterans Integrated Service Network 9 $17,007
Emergency trogarzo Contract · 36C24920N0687 Veterans Integrated Service Network 9 $17,007
Emergency pharmacy trogarzo RX Contract · 36C24920N0540 Veterans Integrated Service Network 9 $17,007
Emergency trogarzo Contract · 36C24920N0434 Veterans Integrated Service Network 9 $17,007
Emergency trogarzo Contract · 36C24920N04341 Veterans Integrated Service Network 9 $17,007

About Theratechnologies Inc.

Theratechnologies Inc., doing business as Exopep, is a commercial stage biopharmaceutical company focused on the development and commercialization of innovative therapies. They currently market prescription products for people with HIV in the United States and Canada.

As a prime contractor, Theratechnologies Inc. has been awarded multiple federal contracts from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 to provide the pharmaceutical drug Trogarzo for the treatment of HIV. These awards have been delivery orders issued under the Pharmaceuticals and Drugs (FSS-61-IB) Multiple Award Schedule contract vehicle. The awards were to provide Trogarzo on an emergency basis as well as standard procurements of the drug. No set-asides were specified.

Theratechnologies Inc. also holds a Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) as a multiple award IDV vehicle. This contract allows the VA and other federal agencies to procure drugs, pharmaceuticals, and hematology-related products from Theratechnologies Inc. through June 2027. The contract has a potential value of $6.1 million over 5 years. Task orders can be awarded by VA Veterans Integrated Service Network 12 facilities to procure pharmaceutical products for VA medical centers in Michigan and Ohio. No set-asides were specified on this IDV contract.

Contract vehicles

Quick answers

What is Theratechnologies Inc.'s UEI?

Theratechnologies Inc.'s Unique Entity ID (UEI) in SAM.gov is PEK6G581HZK5.

What is Theratechnologies Inc.'s CAGE code?

Theratechnologies Inc.'s CAGE code is L07W8.

What is Theratechnologies Inc.'s primary NAICS code?

Theratechnologies Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Is Theratechnologies Inc. registered in SAM.gov?

Theratechnologies Inc.'s SAM.gov registration expired on September 8, 2026.

Which contract vehicles does Theratechnologies Inc. hold?

Theratechnologies Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Theratechnologies Inc.'s most recent federal award?

Theratechnologies Inc.'s most recent federal contract award is Trogarzo (pharmaceutical) (36C24921N0223), from Veterans Integrated Service Network 9, on November 27, 2020.

On GovTribe

See Theratechnologies Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors